Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Audioboom and RCGP eLearning Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and RCGP eLearning Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Respiratory syncytial virus (RSV)

10:02
 
Share
 

Manage episode 436655401 series 2631159
Content provided by Audioboom and RCGP eLearning Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and RCGP eLearning Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Sponsored by Pfizer Limited. Pfizer has had no involvement in the editorial component of this educational material. Editorial and content decisions were made solely by the RCGP.
Respiratory syncytial virus (RSV) is an RNA virus which causes respiratory infections; the most significant clinical effects are in infants and people who are elderly and have chronic medical conditions or immunosuppression. In this podcast, Professor Simon de Lusignan from the RCGP’s Research and Surveillance Centre discusses the new RSV vaccination programme, which offers a one-off vaccine to everyone at the age of 75, with an initial catch-up programme between the ages of 75 and 80. He also touches on monoclonal antibodies and antivirals, which are given in secondary care to children who are at high risk of serious complications if they contract RSV.
  continue reading

131 episodes

Artwork
iconShare
 
Manage episode 436655401 series 2631159
Content provided by Audioboom and RCGP eLearning Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and RCGP eLearning Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Sponsored by Pfizer Limited. Pfizer has had no involvement in the editorial component of this educational material. Editorial and content decisions were made solely by the RCGP.
Respiratory syncytial virus (RSV) is an RNA virus which causes respiratory infections; the most significant clinical effects are in infants and people who are elderly and have chronic medical conditions or immunosuppression. In this podcast, Professor Simon de Lusignan from the RCGP’s Research and Surveillance Centre discusses the new RSV vaccination programme, which offers a one-off vaccine to everyone at the age of 75, with an initial catch-up programme between the ages of 75 and 80. He also touches on monoclonal antibodies and antivirals, which are given in secondary care to children who are at high risk of serious complications if they contract RSV.
  continue reading

131 episodes

كل الحلقات

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play